Ari Robicsek
Overview
Explore the profile of Ari Robicsek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
3342
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boone C, Zink A, Wright B, Robicsek A
JAMA Health Forum
. 2024 Aug;
5(8):e242020.
PMID: 39177984
No abstract available.
2.
Xu H, Usuyama N, Bagga J, Zhang S, Rao R, Naumann T, et al.
Nature
. 2024 May;
630(8015):181-188.
PMID: 38778098
Digital pathology poses unique computational challenges, as a standard gigapixel slide may comprise tens of thousands of image tiles. Prior models have often resorted to subsampling a small portion of...
3.
Kenton N, Gronowski B, Fish D, Vartanian K, Robicsek A
Heliyon
. 2024 Apr;
10(7):e28930.
PMID: 38601697
COVID-19's wide-ranging effects on patients' physical health are well-documented, but comparatively less research has explored the impact on patients' emotional and social experiences. We examined how patients across a multi-state...
4.
Integrating patient-reported physical, mental, and social impacts to classify long COVID experiences
Vartanian K, Fish D, Kenton N, Gronowski B, Wright B, Robicsek A
Sci Rep
. 2023 Sep;
13(1):16288.
PMID: 37770554
Long COVID was originally identified through patient-reported experiences of prolonged symptoms. Many studies have begun to describe long COVID; however, this work typically focuses on medical records, instead of patient...
5.
Vartanian K, Fish D, Gronowski B, Kenton N, Robicsek A
Patient
. 2022 Nov;
16(2):105-116.
PMID: 36336751
Background: While coronavirus disease 2019 (COVID-19) vaccines have high rates of efficacy, fully vaccinated individuals can become infected with COVID-19. Among this population, symptoms tend to be less severe and...
6.
Samia N, Robicsek A, Heesterbeek H, Peterson L
Sci Rep
. 2022 Oct;
12(1):17007.
PMID: 36220870
An ongoing healthcare debate is whether controlling hospital-acquired infection (HAI) from methicillin-resistant Staphylococcus aureus (MRSA) will result in lowering the global HAI rate, or if MRSA will simply be replaced...
7.
Ridgway J, Tideman S, French T, Wright B, Parsons G, Diaz G, et al.
JAMA
. 2022 Sep;
328(15):1559-1561.
PMID: 36149677
No abstract available.
8.
Ridgway J, Tideman S, Wright B, Robicsek A
Open Forum Infect Dis
. 2022 Jul;
9(7):ofac288.
PMID: 35866102
Among 134 223 patients with coronavirus disease 2019 (COVID-19), we assessed how risk of hospitalization changed at different intervals in the pandemic, controlling for prior COVID-19 immunity. In multivariable analysis,...
9.
Ridgway J, Tideman S, Wright B, Robicsek A
JAMA Netw Open
. 2022 Apr;
5(4):e227650.
PMID: 35442459
No abstract available.
10.
Wright B, Tideman S, Diaz G, French T, Parsons G, Robicsek A
Lancet Respir Med
. 2022 Mar;
10(6):557-565.
PMID: 35227415
Background: Research suggests the protection offered by COVID-19 vaccines might wane over time, prompting consideration of booster vaccinations. Data on which vaccines offer the most robust protection over time, and...